Skip to main navigation
Skip to search
Skip to main content
Sort by
Biochemistry, Genetics and Molecular Biology
Deficiency
100%
Genetics
62%
Exome Sequencing
52%
Missense
47%
Inborn Error of Metabolism
47%
Genetic Divergence
37%
Hearing
33%
Fibroblast
31%
Enzyme
30%
Artificial Intelligence
28%
Prevalence
25%
Metabolic Disorder
24%
Proband
23%
Electronic Health Record
23%
Mannosidosis
20%
Next Generation Sequencing
20%
Nonsense-Mediated Decay
18%
Transaldolase
18%
Alpha-Mannosidosis
18%
Serine
18%
Autosomal Recessive Inheritance
17%
Genetic Disorder
16%
Magnetic Resonance Imaging
15%
Genetic Counseling
14%
Amino Acid Substitution
13%
Creatine Kinase
13%
Hematopoietic Stem Cell Transplantation
13%
Allele
12%
Infancy
12%
Retrospective Study
11%
Biotinidase
11%
Missense Mutation
11%
Stop Codon
11%
Metabolite
11%
Mucopolysaccharidosis
11%
Newborn Screening
11%
GM1 Gangliosidosis
11%
Mitochondrial DNA
11%
CDH23
10%
Consanguinity
10%
Genetic Profile
10%
Metabolomics
10%
Genotyping
9%
Schindler Disease
9%
Peroxisome
9%
Pharmacological Chaperone
9%
Phosphoenolpyruvate Carboxykinase
9%
PCK1
9%
Zinc Ion
9%
Isovaleryl-CoA Dehydrogenase
9%
Maroteaux-Lamy Syndrome
9%
Oncogene
9%
Sepiapterin Reductase
9%
Induced Pluripotent Stem Cell
9%
Genomics
9%
Bioenergy
9%
Medical Record
9%
Endocytosis
9%
Calcium Transport
9%
Carbonic Anhydrase
9%
Human Development
9%
Matrix Metalloproteinase
9%
Galactose
9%
Amino Acid Transporter
9%
Phenotypic Heterogeneity
9%
Biogenesis
9%
Animal Model
9%
Reductase
9%
Oxidoreductase
9%
Messenger RNA
9%
Stem Cell Transplantation
9%
Morphology
9%
Enzyme Active Site
9%
Urea Cycle Disorder
9%
Reading Frame
9%
Galactosidase
9%
Farber Disease
9%
Expression Analysis
9%
Astrocyte
9%
Hematopoietic Cell
9%
Genome Sequencing
9%
Proteolysis
9%
Inheritance
9%
Manganese
9%
Lysosomal Storage Disease
8%
Phenylketonuria
7%
Whole Genome Sequencing
7%
Glycogen
7%
Autosomal Recessive Disorder
6%
Molecular Genetics
6%
Energy Metabolism
6%
Pediatrics
6%
Biological Phenomena and Functions Concerning the Entire Organism
6%
Cohort Study
6%
Maturation
6%
Homozygosity
5%
Metabolic Pathway
5%
Amino Acids
5%
Keyphrases
Emirati
48%
United Arab Emirates
29%
Hearing Impairment
28%
Missense Variant
25%
Fibroblasts
24%
Autosomal Recessive
23%
Methylmalonic Acidemia
18%
Inborn Errors of Metabolism
18%
Pompe Disease
18%
Expert Group
18%
Novel mutation
18%
Proband
18%
Early Diagnosis
16%
Early Management
14%
Lysosomal Storage Disease
13%
Pathogenicity
12%
Clinical Heterogeneity
12%
Whole Exome Sequencing
11%
Middle Eastern Population
11%
Reclassification
11%
Transaldolase Deficiency
11%
Liver Disease
11%
Atypical Presentation
11%
Phenotypic Spectrum
11%
Pathogenic Variants
11%
Glutaric Aciduria
11%
Clinical Features
10%
Developmental Delay
9%
Interpregnancy Interval
9%
Schindler Disease
9%
Gaucher
9%
Saposin C
9%
Group Consensus
9%
Etoricoxib
9%
PEX16
9%
Peroxisomal Disorders
9%
Biochemical Disruption
9%
Hypertrophic Osteoarthropathy
9%
Cobalamin C Deficiency
9%
Farber Disease
9%
Pharmacological Chaperone
9%
Bilateral Sensorineural Hearing Loss
9%
SYNJ1
9%
Neonatal Onset
9%
Transaldolase
9%
CDH23 Gene
9%
MPS VI
9%
TALDO1
9%
Orphanet
9%
Citrulline Supplementation
9%
Arginine Supplementation
9%
Perforin Gene
9%
Hemophagocytic Lymphohistiocytosis
9%
Maternal Uniparental Disomy
9%
Cutaneous Features
9%
Novel Pathogenic mutation
9%
Sepiapterin Reductase
9%
Foreskin
9%
Mitochondrial Disease
9%
Endothelial Dysfunction
9%
Metabolic
9%
Gulf Region
9%
Butyl
9%
Neurodegenerative Disorders
9%
Cardiac Disease
9%
Long-term Survival
9%
Genetic Variants
9%
Africa Region
9%
Rare Diseases
9%
Spontaneous Preterm Birth (sPTB)
9%
Mutation Spectrum
9%
Intractable Seizures
9%
Author Names
9%
Endocytic
9%
Middle East and North Africa
9%
Mitochondrial Oxygen Consumption
9%
Null Variants
9%
Splice Site Variant
9%
Knowledge Enhancement
9%
Glutathione
9%
Cobalamin
9%
β-Galactosidase (β-Gal)
9%
Spastic Tetraplegia
9%
Emirati Women
9%
CA5A
9%
SLC2A1
9%
Corresponding Author
9%
GM1 Gangliosidosis
9%
Dehydrogenase
9%
Bedouin
9%
Pathogenicity Prediction Tools
9%
Phosphoenolpyruvate Carboxykinase (PEPCK)
9%
Hepatocellular Carcinoma
9%
Hypocomplementemia
9%
Treatment Choice
9%
Birth Prevalence
9%
C Protein
9%
Metabolic Disorders
9%
Arginine-rich
9%
Consensus Recommendations
9%
Medicine and Dentistry
Glycogen Storage Disease Type II
37%
Early Diagnosis
31%
Diseases
17%
Rare Disease
12%
Electronic Health Record
12%
Lysosomal Storage Disease
12%
Autosomal Recessive Inheritance
12%
Medical Record
11%
Disorders of Mitochondrial Functions
11%
Inborn Error of Metabolism
11%
Mitochondrial DNA Depletion Syndrome
10%
Methylmalonic Acidemia
9%
Etoricoxib
9%
Osteoarthropathy
9%
Farber Disease
9%
Transaldolase
9%
Citrulline
9%
Mucopolysaccharidosis
9%
Genetic Screening
9%
Cross Sectional Study
9%
Liver Disease
9%
Lymphocyte
9%
Exome Sequencing
9%
Heart Disease
9%
Manganese
9%
Adolescence
9%
Fibroblast
9%
Supplementation
9%
Oxygen Consumption
9%
Arginine
9%
Phosphoenolpyruvate Carboxykinase (GTP)
9%
Endothelial Dysfunction
9%
Hepatocellular Carcinoma
9%
Targeted Metabolomics
9%
Premature Labor
9%
Water-Electrolyte Imbalance
9%
Storage Disease
8%
Nitric Oxide
7%
Awareness
6%
Genetic Disorder
6%
Spirometry
6%
Lactic Acidemia
6%
Enzyme Replacement Therapy
6%
Cell Respiration
5%
Education
5%
Respiratory Chain
5%
Carbon Tetrachloride
5%
